Thursday, November 19, 2026

Subscribe

EconomyEdition AlgeriaAlgeria

Algeria and Benin: Saidal tests technology-led pharmaceutical exports in Cotonou

Saidal is relying on Benin to expand its presence in West Africa. The Algerian group is combining medicine sales with technology transfer and training.

Modern facade of an Algerian institution, with officials examining files on pharmaceutical exports.

An opening to West Africa, but not only that

In Algiers, the pharmaceutical industry is no longer content simply to replace imports with local production. It is now seeking growth opportunities abroad, with a simple idea: turn national industrial capacity into a lasting regional presence. In this drive, Benin holds a strategic place because it often serves as a gateway to the West African market. The country is a member of ECOWAS, the Economic Community of West African States, which brings together fifteen member states.

This development is also part of a broader continental trend. In November 2025, the African Union welcomed in Algiers the first African ministerial conference on local production of medicines and health technologies, and endorsed the Algiers Declaration, which supports pharmaceutical and vaccine manufacturing hubs on the continent. Algeria presented itself as an actor able to link health sovereignty with industrial cooperation.

What Saidal came to seek in Cotonou

A visit to Benin by a Saidal delegation led by its chief executive, Younes Bouarara, focused on developing pharmaceutical trade, access for Algerian products to the Beninese market, as well as technology transfer, training and the sharing of expertise. In other words, Algiers is no longer offering only boxes of medicines. It is also putting forward an offer of industrial cooperation.

This approach is not an isolated one. A few days earlier, Saidal had already been in discussions with Niger about supplying essential medicines produced in Algeria. The state-owned group is therefore refining a broader West African strategy based on partnerships country by country, following the same approach: sell, but also establish a technical and regulatory presence.

The choice of Benin is no accident. The Beninese government has said that the Beninese Agency for Medicines and Other Health Products was assessed by the WHO from 6 to 9 July 2026, with a view to reaching maturity level 3. In the WHO classification, this level corresponds to a functional, stable and integrated regulatory system. WHO has also reported supporting ABMed, including through the development of 37 standard operating procedures.

In practice, this regulatory progress matters to a foreign manufacturer. A market where the medicines authority is taking shape offers greater clarity on registration, quality control and distribution. For Saidal, this could make a lasting foothold easier, provided it works within local rules rather than circumventing them.

A still-small market, but with real room to grow

The figures give a sense of the potential. Benin’s imports of pharmaceutical products amounted to just under $24 million in 2023, after peaking at close to $46 million in 2021, according to UNCTAD data. Algerian pharmaceutical exports, meanwhile, reached $46 million in 2024, according to a statement by Algeria’s ministry responsible for the sector, reported by Radio Algérienne.

The comparison between these two figures should not be taken as an automatic projection. It does, however, show that there is room for Algerian products, including in a modest-sized market such as Benin. Saidal does not need to capture the entire market to find it worthwhile. Even a limited share could be valuable, especially if accompanied by services, training and technical cooperation.

This approach aligns with the strategy of Algeria’s Ministry of Pharmaceutical Industry, which emphasises exports, subcontracting and the transformation of the Saidal group into a public hub for health sovereignty. The message is clear: Algeria wants to produce more at home to import less, then export more to the continent.

The industrial case is bolstered by another signal. In July 2026, Jean Kaseya, director-general of Africa CDC, said that Algeria produced more than 80% of its health product needs. This places the country among the few African states able to underpin their health policies with a solid production base.

What this push means for Algiers and the region

For Algeria, the stakes go beyond Saidal. The country is seeking to turn its industrial capacity into diplomatic and economic leverage. This is a way to make the most of public investment, strengthen the local productive sector and move beyond an approach in which medicine is seen as a mere budgetary expense. Recent developments point in the same direction, including projects for raw-material plants in Batna and Médéa, as well as industrial agreements with foreign partners to produce more sophisticated treatments locally.

For Benin, cooperation with Algiers could strengthen efforts to secure supplies. The country is developing its regulatory framework, improving its procedures and seeking to better control the quality of products in circulation. In this context, an industrial partner able to provide medicines, technology and training could support the upgrading of Benin’s pharmaceutical system.

The regional implications are broader still. ECOWAS is advancing the economic integration of its members, while the African Union is encouraging local and regional health value chains. If ties between North African manufacturers and West African regulators grow closer, the continent could reduce some of its dependence on distant imports. The issue is not merely commercial. It concerns access to medicines, the resilience of health systems and the movement of skills.

What happens next will depend on the two countries’ ability to turn political intent into concrete mechanisms: product registration, quality standards, distribution, financing and the possible partial localisation of some production. That is where the difference lies between a ceremonial visit and genuine African industrial cooperation.

Automatic translation. Original French version

The quiz

The African economy in six questions

6 questions